Identification of Linear Peptide Immunogens with Verified Broad-spectrum Immunogenicity from the Conserved Regions within the Hemagglutinin Stem Domain of H1N1 Influenza Virus

References

• Arvia R, Corcioli F, Pierucci F, Azzi A. 2014. Molecular markers of influenza B lineages and clades. Viruses. 6:4437–46.
   PubMed Web of Science ®Google Scholar
• Boni MF. 2008. Vaccination and antigenic drift in influenza. Vaccine. 26S:C8–14.
   Google Scholar
• Ekiert DC, Bhabha G, Elsliger MA, Friesen RHE, Jongeneelen M, Throsby M, Goudsmit J, Wilson IA. 2009. Antibody recognition of a highly conserved influenza virus epitope. Science. 324:246–52.
   PubMed Web of Science ®Google Scholar
• Follin P, Lindqvist A, Nystrom K, Lindh M. 2019. A variety of respiratory viruses found in symptomatic travelers returning from countries with ongoing spread of the new influenza A(H1N1)v virus strain. Eurosurveillance. 14:1–3.
   Google Scholar
• Gong X, Yin H, Shi TH, He XQ, Yu YJ, Guan SS, Kuai ZY, Haji NM, Haji NM, Kong W, et al. 2016. Evaluation of the immunogenicity and protective effects of a trivalent chimeric norovirus P particle immunogen displaying influenza HA2 from subtypes H1, H3 and B. Emerg Microbes Infect. 5:e51–59.
   PubMed Web of Science ®Google Scholar
• Gupta P, Kamath AV, Park S, Chiu H, Lutman J, Maia M, Tan MW, Xu M, Swem L, Deng R. 2016. Preclinical pharmacokinetics of MHAA4549A, a human monoclonal antibody to influenza A virus, and the prediction of its efficacious clinical dose for the treatment of patients hospitalized with influenza A. MAbs. 8:991–97.
   PubMed Web of Science ®Google Scholar
• Han JA, Kang YJ, Shin C, Ra JS, Shin HH, Hong SY, Do Y, Kang S. 2014. Ferritin protein cage nanoparticles as versatile antigen delivery nanoplatforms for dendritic cell (DC)-based vaccine development. Nanomedicine. 10:561–69.
   PubMed Web of Science ®Google Scholar
• Inn KS, Lee GJ, Quan FS. 2014. A pandemic H1N1 influenza virus-like particle vaccine induces cross-protection in mice. Immunol Invest. 43:236–54.
   PubMed Web of Science ®Google Scholar
• Kanekiyo M, Wei CJ, Yassine HM, Tamney PM, Boyington JC, Whittle JRR, Rao SS, Kong WP, Wang LS, Nabel GJ. 2013. Self-assembling influenza nanoparticle vaccines elicit broadly neutralizing H1N1 antibodies. Nature. 499:102–06.
   PubMed Web of Science ®Google Scholar
• Keshavarz M, Namdari H, Arjeini Y, Mirzaei H, Salimi V, Sadeghi A, Mokhtari-Azad T, Rezaei F. 2019. Induction of protective immune response to intranasal administration of influenza virus-like particles in a mouse model. J Cell Physiol. 234:16643–52.
   Web of Science ®Google Scholar
• Kim SM, Kin YI, Park SJ, Kim EH, Azzi HI, Si YJ, Lee IW, Song MS, Choi YK. 2017. Vaccine efficacy of inactivated, chimeric hemagglutinin H9/H5N2 avian influenza virus and its suitability for the marker vaccine strategy. J Virol. 91:e01693–1710.
   PubMed Web of Science ®Google Scholar
• Lee EB, Jeon HM, Kim CU, Park SM, Cho G, Kim HJ, Kim Y, Kim DJ, Kim YS, Lee H, et al. 2019a. Attachment of flagellin enhances the immunostimulatory activity of a hemagglutinin-ferritin nano-cage. Nanomedicine. 17:223–35.
   PubMed Web of Science ®Google Scholar
• Lee GJ, Chu KB, Inn KS, Moon EK, Quan FS. 2019b. Vaccine efficacy induced by 2009 pandemic H1N1 virus-like particles differs from that induced by split influenza virus. Immunol Invest. 1–13. doi:https://doi.org/10.1080/08820139.2019.1694539
   PubMed Web of Science ®Google Scholar
• Li Z, Wan ZM, Li TF, Xie Q, Sun HW, Chen HJ, Liang GC, Shao HX, Qin AJ, Ye JQ. 2019. A novel linear epitope crossing Group 1 and Group 2 influenza A viruses located in the helix A of HA2 derived from H7N9. Vet Microbiol. 228:39–44.
   PubMed Web of Science ®Google Scholar
• Lobo SM, Watanabe ASA, Salomao MLM, Queiroz F, Gandolfi JV, de Oliveira NE, Covello LHS, Sacillotto GH, de Godoy LG, Simoes ES, et al. 2019. Excess mortality is associated with influenza A (H1N1) in patients with severe acute respiratory illness. J Clin Virol. 116P:62–68.
   Google Scholar
• Moon EK, Kang HJ, Chu KB, Lee SH, Lee DH, Soh Y, Quan FS. 2019. Immune correlates of protection induced by virus-like particles containing 2009 H1N1 pandemic influenza HA, NA or M1 proteins. Immunol Invest. 48:355–66.
   PubMed Web of Science ®Google Scholar
• Oboho IK, Reed C, Gargiullo P, Leon M, Aragon D, Meek J, Anderson EJ, Ryan P, Lynfield R, Morin C, et al. 2016. Benefit of early initiation of influenza antiviral treatment to pregnant women hospitalized with laboratory-confirmed influenza. J Infect Dis. 214:507–15.
   PubMed Web of Science ®Google Scholar
• Pavia A. 2019. One hundred years after the 1918 pandemic: new concepts for preparing for influenza pandemics. Curr Opin Infect Dis. 32(4):365–71.
   PubMed Web of Science ®Google Scholar
• Reid AH, Taubenberger J. 1999. The 1918 flu and other influenza pandemics: “Over there” and back again. Lab Invest. 79:95–101.
   PubMed Web of Science ®Google Scholar
• Roald N. 2019. Dynamic aspects of the immunoglobulin structure. Immunol Invest. doi:https://doi.org/10.1080/08820139.2019.1597110
   Google Scholar
• Stepanova LA, Mardanova ES, Shuklina MA, Blokhina EA, Kotlyarov RY, Potapchuk MV, Kovaleva AA, Vidyaeva IG, Korotkov AV, Eletskaya EI, et al. 2018. Flagellin-fused protein targeting M2e and HA2 induces potent humoral and T-cell responses and protects mice against various influenza viruses a subtypes. J Biomed Sci. 25(1):33.
   PubMed Web of Science ®Google Scholar
• Vareckova EN, Cox N, Klimov A. 2002. Evaluation of the subtype specificity of monoclonal antibodies raised against H1 and H3 subtypes of human influenza A virus hemagglutinins. J Clin Microbiol. 40(6):2220–23.
   PubMed Web of Science ®Google Scholar
• Vemula SV, Sayedahmed EE, Sambhara S, Mittal SK. 2017. Vaccine approaches conferring cross- protection against influenza viruses. Expert Rev Vaccines. 16(11):1141–54.
   PubMed Web of Science ®Google Scholar
• Wang Y, Deng L, Kang SM, Wang BZ. 2018. Universal influenza vaccines: from viruses to nanoparticles. Expert Rev Vaccines. 17:967–76.
   PubMed Web of Science ®Google Scholar
• Wei HL, Lenz SD, Thompson DH, Pogranichniy RM. 2014. DNA-epitope vaccine provided efficient protection to mice against lethal dose of influenza A virus H1N1. Viral Immunol. 27:14–19.
   PubMed Web of Science ®Google Scholar
• Zhao GY, Lin YP, Du LY, Guan J, Sun SH, Sui HY, Kou ZH, Chan CC, Guo Y, Jiang SB, et al. 2010. An M2e-based multiple antigenic peptide vaccine protects mice from lethal challenge with divergent H5N1 influenza viruses. Virol J. 7:9.
   PubMed Web of Science ®Google Scholar